Clinical Trials Sponsored by Clinical trial center Rhine-Main

Total 1095 results

NCIC Clinical Trials Group

Completed

Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

Canada
NCIC Clinical Trials Group

Completed

ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

Ovarian Cancer

United States, Canada, United Kingdom
NCIC Clinical Trials Group

Completed

SarCNU in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

Canada
NCIC Clinical Trials Group

Completed

Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia

Leukemia

Canada, France
NCIC Clinical Trials Group

Completed

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Quality of Life | Pain | Prostate Cancer

Canada
NCIC Clinical Trials Group

Terminated

Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids

Quality of Life | Oral Complications

Canada
NCIC Clinical Trials Group

Completed

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Canada, United States
NCIC Clinical Trials Group

Completed

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

Breast Cancer

United States, Canada
NCIC Clinical Trials Group

Completed

Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

Pancreatic Cancer

United States, Canada, Australia, Singapore, Belgium, United Kingdom, Israel, New Zealand, China, Germany, Brazil, Poland, Italy, Argentina, Romania, Greece, Chile, Hong Kong, Mexico
NCIC Clinical Trials Group

Completed

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Tamoxifen in Treating Women With High-Risk Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer

Head and Neck Cancer

Canada
NCIC Clinical Trials Group

Terminated

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

Canada
NCIC Clinical Trials Group

Completed

Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Lung Cancer

Canada
NCIC Clinical Trials Group

Terminated

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Bladder Cancer

Canada
NCIC Clinical Trials Group

Completed

Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer

Prostate Cancer

Canada
NCIC Clinical Trials Group

Completed

Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

Canada, Singapore, Australia, Romania, Argentina, Brazil
NCIC Clinical Trials Group

Completed

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Kidney Cancer | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Bladder Cancer
NCIC Clinical Trials Group

Completed

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Prostate Cancer

United States, Canada
NCIC Clinical Trials Group

Completed

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Colorectal Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme

Brain and Central Nervous System Tumors

Canada
NCIC Clinical Trials Group

Completed

AEG35156 and Docetaxel in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
NCIC Clinical Trials Group

Completed

Topotecan in Treating Patients With Recurrent Brain Tumors

Brain and Central Nervous System Tumors

Canada
NCIC Clinical Trials Group

Completed

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Quality of Life | Pain | Fatigue | Lung Cancer | Pulmonary Complications | Nausea and Vomiting

Canada
NCIC Clinical Trials Group

Completed

Treatment for Chronic Pain in Patients With Advanced Cancer

Pain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous/Nonmalignant Condition

Canada
NCIC Clinical Trials Group

Completed

Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer

Lung Cancer

Canada
NCIC Clinical Trials Group

Completed

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Cancer

Canada
NCIC Clinical Trials Group

Completed

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

Prostate Cancer | Precancerous/Nonmalignant Condition

Canada
PD Dr Markus Möhler
Johannes Gutenberg University Mainz; Interdisciplinary Center for Clinical...

Completed

Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)

Adenocarcinoma

Germany
Philipps University Marburg Medical Center
Johannes Gutenberg University Mainz; Philipps University Marburg Coordination...

Terminated

Alternative Dosing Regimens in the Pharmacotherapy of Insomnia (ALPHASOM)

Insomnia

Germany
Cancer Research Campaign Clinical Trials Centre

Unknown

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Bladder Cancer

United Kingdom
High Point Clinical Trials Center
Ferox Therapeutics

Terminated

Insulin Tolerance Test Study in Patients With Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

United States
Cancer Research Campaign Clinical Trials Centre

Completed

Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters

Thromboembolism

United Kingdom
Cancer Research Campaign Clinical Trials Centre

Unknown

Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery

Breast Cancer

United Kingdom
Cancer Research Campaign Clinical Trials Centre

Completed

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Lymphoma | Testicular Germ Cell Tumor | Breast Cancer | Small Intestine Cancer | Ovarian Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Infection | Extragonadal Germ Cell Tumor

United Kingdom
Cancer Research Campaign Clinical Trials Centre

Completed

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Breast Cancer

United Kingdom
Cancer Research Campaign Clinical Trials Centre

Completed

Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer

Colorectal Cancer

United Kingdom
Cancer Research Campaign Clinical Trials Centre

Completed

Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

Lymphoma

United Kingdom
NCIC Clinical Trials Group
AstraZeneca

Completed

AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

Canada
NCIC Clinical Trials Group
Bayer

Completed

Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

Canada
NCIC Clinical Trials Group
AstraZeneca

Completed

AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Pancreatic Cancer

Canada
Haemophilia Centre Rhine Main
Skane University Hospital; University of Bonn; Hopital Cardiologique Louis Pradel...

Recruiting

A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI

Haemophilia A

Germany
Eindhoven University of Technology
Clinical Trial Center Maastricht B.V.

Recruiting

Priming the Epileptic Brain: tVNS to Improve Efficacy of add-on AED in Patients With Focal Epilepsy (PREP)

Focal Epilepsy

Netherlands
NCIC Clinical Trials Group
Pfizer

Completed

PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer

Lung Cancer

Taiwan, Canada, Australia, Italy, New Zealand, United States, Thailand, Korea, Republic of, Brazil, Argentina, Philippines, Peru
NCIC Clinical Trials Group
Pfizer

Completed

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Canada
NCIC Clinical Trials Group
GlaxoSmithKline

Completed

Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer

Breast Cancer

Canada
NCIC Clinical Trials Group
GlaxoSmithKline

Completed

MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy

Lung Cancer

Canada

Clinical Trials Sponsored by Clinical trial center Rhine-Main

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations